Long-Term Follow-Up of Oral Glucose Tolerance Test–Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)
Open Access
- 1 July 2008
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 31 (7), 1321-1323
- https://doi.org/10.2337/dc07-2017
Abstract
OBJECTIVE—We investigated the natural history of glucokinase (GCK)-related maturity-onset diabetes of the young type 2 (MODY2), notably the factors associated with deterioration of hyperglycemia over time. RESEARCH DESIGN AND METHODS—We report an 11-year follow-up of glucose tolerance and indexes of insulin secretion and insulin sensitivity derived from oral glucose tolerance tests in 33 MODY2 subjects. RESULTS—The variation between tests of glucose tolerance (expressed as the area under the glucose curve) was 6.9 ± 3.2% (mean ± SEM), but individual results ranged from −20 to 61%. Deterioration of glucose tolerance between tests was associated with decreased insulin sensitivity, while insulin secretion remained stable. CONCLUSIONS—Glucose tolerance can remain stable over many years in subjects with MODY2 due to the relative stability of the GCK-related β-cell defect. However, the development of insulin resistance may have an important role in the deterioration of the glucose tolerance and in the long-term evolution of the disorder.Keywords
This publication has 8 references indexed in Scilit:
- Maturity Onset Diabetes of the Young Type 2Published by S. Karger AG ,2004
- Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the YoungThe New England Journal of Medicine, 2001
- beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.Diabetes, 2001
- Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.Diabetes Care, 2000
- Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care, 1999
- Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects.JCI Insight, 1996
- Assessment of insulin sensitivity in glucokinase-deficient subjectsDiabetologia, 1996
- Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations.JCI Insight, 1994